ABSTRACT Objective: To investigate the effect of postoperative intravenous additional tranexamic acid (TXA) on blood loss in total knee arthroplasty (TKA). Methods: A restropective study was carried out in Second Hospital of Bazhou City. 150 patients undergoing primary unilateral TKA from department of bone surgery between March 2015 and August 2018 were divided into control group (n=89) and additional group (n=61). The patients in control group were received intravenous injection of 20 mg·kg-1 TKA before skin incision, and intravenous injection of 10mg·kg-1 TKA 3h later, additional group was received intravenous injection of 20 mg·kg-1 TKA before skin incision, and intravenous injection of 10 mg·kg-1 TKA 3h and 6h later. Total blood loss, recessive blood loss, maximum Hb decrease after surgery, blood transfusion rate, operation time, hospitalization time, fibrin degradation product (FDP), d dimer (D D), thrombosis, wound complications were observed and compared between the two groups.Results: The total blood loss, recessive blood loss, maximum Hb decreased after surgery in additional group were lower than those in control group, the differences were statistically significant (P<0.05). However, there were no statistically significant differences in blood transfusion rate, operation time and hospitalization time between the two groups (P>0.05). Symptomatic pulmonary embolism and deep venous thrombosis of lower extremity did not occur in both groups. There was no statistically significant difference in the level of FDP, d d and the incidence of 3d intramuscular vein thrombosis between the two groups (P>0.05), and the incidence of ecchymosis area >1% in additional group was lower than that in control group (P<0.05). Conclusion: One additional dose of TXA could effectively reduce blood loss after TKA without increasing the risk of deep vein thrombosis. |